Stock Movers

On this episode of Stock Movers: - Shares of Dynavax Technologies (DVAX) soared in premarket trading after Sanofi agreed to buy Dynavax for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesda...

On This episode of Stock Movers: - BP agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion. - French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion — and some analysts see the potential for even more gains -...

On This episode of Stock Movers: - BP Plc agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion. - Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as the French drugmaker tries to expand a vaccines business currently anchored by its flu shot franchise. - Fresnillo and other european mining stock...

On this episode of Stock Movers: - Novo Nordisk (NVO) shares rallied in trading today following the drugmaker getting US approval to sell a pill version of its blockbuster obesity shot Wegovy. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term. The pill is...

On this episode of Stock Movers: - Novo Nordisk (NVO) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ab...

On this episode of Stock Movers: - Novo Nordisk (NOVOB) won approval to sell a pill version of its obesity shot Wegovy in the US, to help people lose weight or maintain previous weight loss over the long term. The company will start selling the pill in the US in early January, and it is approved based on the results of the Oasis 4 trial, which found people taking the pill lost about 13.6% of their...

On this episode of Stock Movers: - Novo Nordisk (NOVOB) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly (LLY). The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker&rs...

On this episode of Stock Movers: - Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved t...

On this episode of Stock Movers: - Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved t...

On This episode of Stock Movers: - Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. - Ryanair was fined more than €255 million ($300 million) by Italy’s antitrust watchdog for allegedly using an “abusive strategy” to thwart third-party travel agenci...

On This episode of Stock Movers: - Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. - Orsted said it’s considering “all options” including legal action as it weighs how to respond to a US decision to suspend leases for five offshore wind farms, according...

On this episode of Stock Movers: - Warner Bros. Discovery (WBD) shares rallied in trading today after word that Larry Ellison is throwing his personal fortune behind Paramount Skydance Corp.’s bid for it, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix. Paramount has been aggressively pursuing Warner Bros. for months and Ellison was ta...

On this episode of Stock Movers: - Warner Bros. Discovery (WBD) shares rose on news that Larry Ellison is throwing his personal fortune behind Paramount Skydance’s bid for it, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix. Both suitors moved on Monday to strengthen the financial backing for their offers, though they stopped short of...

On this episode of Stock Movers: - Warner Bros Discovery (WBD) shares are up 3.9% in premarket trading after Larry Ellison agreed to provide an irrevocable personal guarantee of $40.4 billion of the equity financing for the offer and any damages claims against Paramount. Paramount Skydance rises 3.1%, while Netflix ticks 0.4% higher. - Marvell Technology (MRVL) shares are up 2.1% in premarket trad...

On this episode of Stock Movers: - Warner Bros Discovery shares are up 3.9% in premarket trading after Larry Ellison agreed to provide an irrevocable personal guarantee of $40.4 billion of the equity financing for the offer and any damages claims against Paramount. Paramount Skydance rises 3.1%, while Netflix ticks 0.4% higher. - Nelson Peltz’s Trian Fund Management and General Catalyst agre...

On this episode of Stock Movers: - Shares of Warner Bros. Discovery (WBD) moved higher ahead of the US market open as Paramount Skydance Corp. sweetened its bid for WBD, including offering a personal financial guarantee by Oracle Corp. Chairman Larry Ellison, as it seeks to beat out a rival bid from Netflix Inc. Ellison has agreed to personally guarantee $40.4 billion in equity financing for Param...

On this episode of Stock Movers: - Netflix (NFLX) has refinanced part of a $59 billion bridge loan to support its potential acquisition of Warner Bros. Discovery Inc. The streaming giant secured a $5 billion revolving credit facility and two $10 billion delayed-draw term loans to refinance part of the bridge facility it took out for its Warner Bros. bid, according to a filing on Monday. That leave...

On This episode of Stock Movers: - BHP and other miners are up as gold rose to an all-time high, as escalating geopolitical tensions and bets on further US rate cuts added momentum to the best annual performance in more than four decades. - Dairy makers are being hit after news that China will impose preliminary anti-subsidy duties of 21.9% to 42.7% on certain dairy products imports from the Europ...

On This episode of Stock Movers: - Telecom Italia’s board approved a proposal to convert the company’s savings shares into ordinary stock and to reduce its share capital, moving toward a long-delayed change that would simplify its capital structure. - Fresnillo and other miners are up as gold rose to an all-time high, as escalating geopolitical tensions and bets on further US rate cuts...

On this episode of Stock Movers: - Computer data storage companies SanDisk (SNDK) and Micron (MU) both saw a boost to their share prices, coinciding with the rise of AI and computer technology spaces - Rivian (RIVN) sees their stock price climb 10.7% with anticipation for the release of the R2, their mid-size SUV - Frozen potato product brand Lamb Weston (LW) dropped 26% after a consistent decline...

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar. On this episode of Stock Movers: - Cruise group Carnival (CCL) sees their share price jump by over 9% today as the company expects profits to increase next year - WhiteFiber (WYFI) shares rose aft...

On this episode of Stock Movers: - Oracle (ORCL) sees a 7% boost after it was announced that they would be leading a group of buyers in purchasing TikTok. - Nike (NKE) is down for the fourth day in a row with an 11% drop today. Sales are continuing to decline, citing difficulty in China as well as their Converse brand. - BioMarin Pharmaceutical (BMRN) is up big at 17% with their agreement to buy A...

On this episode of Stock Movers: - Nike (NKE) shares sink after the company warned that sales will decline this quarter amid persistent weakness in China and at its Converse brand. The world’s largest sportswear company expects revenue to be down in the low-single digits in the three months that started Dec. 1, a surprising turn after two straight periods of growth. - FedEx (FDX) shares fall...

On this episode of Stock Movers: - BioMarin (BMRN) shares rise after the company agreed to buy Amicus Therapeutics Inc. for about $4.8 billion, helping the biotech company expand its portfolio of treatments for rare diseases. - FedEx (FDX) shares fall the most intraday since June 25, as the shipping firm upgraded FY targets, but to a lower magnitude than the 2Q earnings beat as it suffers from a s...

On this episode of Stock Movers: - Shares of Nike (NKE) fell as much as 10 percent in premarket trading as the sportswear retailer’s third-quarter guidance disappointed investors, with its turnaround hampered by weak sales in China and the Converse brand. It expects third-quarter sales to be down low-single digits, and gross margins to shrink by roughly 2 percentage points due to tariffs. No...